On Tuesday, Shares of Allergan plc Ordinary Shares (NYSE:AGN), subtract -1.83% and closed at $195.80 in the last trading session. The last trading range of the stock ranges between $193.58 and $201.39. The company’s Market capitalization is $74.81 Billion with the total Outstanding Shares of 375.08 million. Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, womens health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, in addition to dermatology and plastic surgery. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, in addition to other dry eye products. In addition, it distributes generic and branded pharmaceutical products mainly to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians offices. Allergan plc has a partnershipwith T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species.
Twenty-First Century Fox Inc (NASDAQ:FOX), dropped -0.40% and closed at $27.08 in the last trading session. The last trading range of the stock ranges between $26.84and $27.30. The company’s Market capitalization is $51.40 Billion with the total Outstanding Shares of 798.52 million. Twenty-First Century Fox, Inc. (“21st Century Fox” or the “Company” — NASDAQ: FOXA, FOX) recently stated financial results for the three months ended September 30, 2016.
The Company stated quarterly income from continuing operations attributable to stockholders of $827 million ($0.44 per share), as contrast to $678 million ($0.34 per share) stated in the prior year quarter. Apart From the net income effects of Other, net and adjustments to Equity earnings of associates, counting adjustments related to Sky plc (“Sky”) and Endemol Shine Group, adjusted quarterly earnings per share from continuing operations attributable to shareholders1 was $0.51 as compared to $0.38 stated in the same quarter of the prior year.
The Company stated total quarterly revenues of $6.51 billion, a $429 million, or 7%, increase from the $6.08 billion of revenues stated in the prior year quarter. This increase mainly reflects higher associate and advertising revenues generated at our Cable Network Programming segment and higher content revenues generated at the Filmed Entertainment segment. The adverse impact of foreign exchange rates influenced quarterly revenue growth by $77 million.